Skip to main content
Back to Top

 

Long-term Survivorship Care after Cancer Treatment: A Workshop

  • Event Summary

    Improvements in cancer treatment, new technologies that enable early detection of cancer, and changing demographics—including the aging of the baby boomer population—have contributed to a growing number of cancer survivors in the United States. The number of people who are likely to live at least 5 years following a cancer diagnosis is expected to increase by 37 percent over the next decade, and approximately 40 percent of cancer survivors are living 10 years or more post diagnosis. In 2014, there were an estimated 14.5 million cancer survivors nationwide; by 2022, 18 million cancer survivors are projected.  

    In 2006, an Institute of Medicine report, Lost in Transition, made recommendations to improve the quality of care that cancer survivors receive, in recognition that this population is at ask risk for an array of long-term side effects and delayed-onset late effects of cancer and cancer treatment, as well as significant psychosocial and financial impacts of cancer diagnosis and treatment. Since then, coordinated efforts to recognize and address the unique needs of cancer survivors have increased, including efforts to improve the evidence base for cancer survivorship care, as well as efforts to identify best practices in the delivery of high-quality cancer survivorship care. 

    The National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine will hold a public workshop in July 2017 to examine progress in cancer survivorship care over the past decade and to consider potential actions to improve the planning, management, and delivery of cancer survivorship care. The workshop will feature invited presentations and panel discussions on topics that may include: 

    • An overview of the health risks and late effects experienced by cancer survivors. 
    • The current evidence base to improve the quality of life for cancer survivors, including the identification, prevention, and reduction of long-term toxicities and second malignancies associated with prior cancer treatment.
    • Strategies for early integration of psychosocial support in survivorship care.
    • Opportunities to overcome challenges in accessing health care and minimizing the financial burden for cancer survivors. 
    • Implementation models and emerging strategies for coordinated cancer survivorship care in primary and specialty care settings, including the use of survivorship care plans tailored to a patient’s diagnosis and life course. 
    • Changes in the landscape of cancer survivorship care over the past decade.

    The workshop will also be live webcast on this website.  Register: http://nationalacademies.org/hmd/Activities/Disease/NCPF/2017-July-24.aspx

    Planning Committee Members
    Patricia A. Ganz (co-chair), University of California, Los Angeles
    Ronald Kline (co-chair), Centers for Medicare and Medicaid Services
    Neeraj K. Arora, Patient Centered Outcomes Research Institute
    Cathy J. Bradley, University of Colorado Comprehensive Cancer Center
    Natasha Buchanan Lunsford, Centers for Disease Control and Prevention
    R. Adams Dudley, University of California, San Francisco 
    Shelley Fuld Nasso, National Coalition for Cancer Survivorship 
    Darci L. Graves, Centers for Medicare & Medicaid Services 
    Lee M. Krug, Bristol-Myers Squibb
    Greta Massetti, Centers for Disease Control and Prevention
    Mary S. McCabe, Independent Consultant
    Larissa Nekhlyudov, Brigham & Women's Hospital, Harvard Medical School
    Julia H. Rowland, National Cancer Institute
    Rebekkah Schear, LIVESTRONG Foundation
    Richard Schilsky, American Society of Clinical Oncology
    Wendy A. Woodward, University of Texas MD Anderson Cancer Center